China Universal Asset Management Co., Ltd. Gritstone Bio, Inc. Transaction History

China Universal Asset Management Co., Ltd.

$893 Million
Q3 2024

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 May 21, 2024	BUY	$1.19 - $2.26 $1,458 - $2,770	1,226 Added 105.15%	2,392 $4,000
Q3 2023 Oct 30, 2023	BUY	$1.19 - $2.26 $1,458 - $2,770	1,226 Added 105.15%	2,392 $4,000
Q2 2023 May 21, 2024	BUY	$1.66 - $3.03 $59 - $109	36 Added 3.19%	1,166 $2,000
Q2 2023 Jul 27, 2023	BUY	$1.66 - $3.03 $59 - $109	36 Added 3.19%	1,166 $2,000
Q1 2023 May 21, 2024	BUY	$2.13 - $3.74 $602 - $1,058	283 Added 33.41%	1,130 $3,000
Q1 2023 Apr 27, 2023	BUY	$2.13 - $3.74 $602 - $1,058	283 Added 33.41%	1,130 $3,000
Q4 2022 May 21, 2024	BUY	$2.17 - $3.92 $1,837 - $3,320	847 New	847 $2,000
Q4 2022 Jan 31, 2023	BUY	$2.17 - $3.92 $355 - $642	164 Added 24.01%	847 $3,000
Q3 2022 Oct 21, 2022	BUY	$2.46 - $4.75 $1,680 - $3,244	683 New	683 $2,000

Others Institutions Holding GRTS

# of Institutions

Shares Held

35.4M

Call Options Held

395K

Put Options Held

132K

View Full List

About Gritstone bio, Inc.

Ticker GRTS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,006,896
Market Cap $2.19M
Description
Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing immunotherapies against multiple cancer types and infectious diseases. Its lead product candidate is GRANITE, a neoantigen-based immunotherapy for the treatment of solid tumors, including metastatic non-small cell lung cancer, as well as gastroesophageal, bladder ...

More about GRTS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of China Universal Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on China Universal Asset Management Co., Ltd. with notifications on news.

Account